Table 5 Interactions between CAV-1 rs3807992 and healthy dietary intake on CVDs risk factors
|  | β (95%CI) (AA + AG) 1(Ref) GG |  | ||
|---|---|---|---|---|
Crude | P* | Adjusted | P** | |
TC (mg/dl) | −0.02 (−.07,0.03) | 0.44 | − 0.04 (−.09,0.006) | 0.08 |
HDL-C (mg/dl) | 6.67 (−.13,13.48) | 0.05 | 7.74 (−0.76,14.72) | 0.03 |
LDL-C (mg/dl) | 7.68 (−7.43,22.81) | 0.31 | −2.53(−18.19,13.12) | 0.75 |
TC/HDL | −0.86 (−1.81,0.08) | 0.07 | −1.01 (− 1.97,0.05) | 0.03 |
LDL/HDL | −0.07 (−.44,0.29) | 0.67 | − 0.31 (−.67,0.04) | 0.08 |
TG (mg/dl) | −0.09 (− 0.61,0.42) | 0.72 | −4.33 (−47.04,38.37) | 0.84 |
ALT (IU.L) | −2.64(−11.06,5.7) | 0.53 | −3.38 (− 12.27,5.5) | 0.45 |
AST (IU.L) | −0.95(−5.55,3.97) | 0.74 | −1.34 (−6.29,3.61) | 0.59 |
hs-CRP (mg/L) | −0.38 (− 0.74, − 0.02) | 0.03 | −0.34 (− 0.68,-0.007) | 0.04 |
MCP-1 (ng/ml) | −51.88 (− 112.93,9.17) | 0.09 | −60.89 (− 124.51,2.72) | 0.06 |
PAI-1 (ng/ml) | −12.45 (− 34.91,10.01) | 0.27 | − 12.42(− 36.24,11.4) | 0.30 |
IL1B (pg/ml) | − 0.16 (− 0.51,0.18) | 0.35 | − 0.33 (− 0.69,0.02) | 0.06 |